🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524277-16-00
Completed Phase I/II

A Phase 1 Study of Fentanyl Vaccine

2025-524277-16-00 · tracked via the Priya Life Science EU tracker
Sponsor
ARMR Sciences Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Environment and Public Health
Decision date
23/02/2026
Enrollment target
130
Sites
Netherlands

Condition studied

Opioid induced respiratory depression

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524277-16-00 on CTIS ↗ ← All trials in the EU